Literature DB >> 12162160

[Warfarin fetopathy].

C Bony1, F Zyka, I Tiran-Rajaofera, T Attali, S De Napoli, J L Alessandri.   

Abstract

UNLABELLED: We report a case of warfarin embryopathy. This disease affects more than 6% of fetuses exposed in utero to a vitamin K antagonist. OBSERVATION: A child whose mother was treated with acenocoumarol because of a mechanical heart valve presented with signs of warfarin embryopathy. He showed chondrodysplasia punctata with telebrachydactyly, facial dysmorphism with nasal hypoplasia, a cataract, and a bilateral pyeloureteral junction syndrome. COMMENTS: Characteristics of this drug induced embryopathy are reminded, while bearing in mind the conflict of interests between the mother and the fetus. The mechanisms of this embryopathy are debated in light of the recent knowledge concerning fetal metabolism of vitamin K.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12162160     DOI: 10.1016/s0929-693x(01)00970-8

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  2 in total

1.  My approach to performing a perinatal or neonatal autopsy.

Authors:  H C Wainwright
Journal:  J Clin Pathol       Date:  2006-07       Impact factor: 3.411

2.  Warfarin-Associated Diaphragmatic Hernia: An Unusual Diagnosis.

Authors:  Cristina Vilhena; Cátia Gameiro; Cláudia Tomás; Antónia Santos; Raquel Ilgenfritz
Journal:  Case Rep Obstet Gynecol       Date:  2015-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.